<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23468506</PMID><DateCompleted><Year>2013</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><Issue>10</Issue><PubDate><Year>2013</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome.</ArticleTitle><Pagination><StartPage>5645</StartPage><EndPage>5656</EndPage><MedlinePgn>5645-56</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JVI.02655-12</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) has emerged as a major cause of neurological disease following the near eradication of poliovirus. Accumulating evidence suggests that mammalian microRNAs (miRNAs), a class of noncoding RNAs of 18 to 23 nucleotides (nt) with important regulatory roles in many cellular processes, participate in host antiviral defenses. However, the roles of miRNAs in EV71 infection and pathogenesis are still unclear. Here, hsa-miR-296-5p expression was significantly increased in EV71-infected human cells. As determined by virus titration, quantitative real-time PCR (qRT-PCR), and Western blotting, overexpression of hsa-miR-296-5p inhibited, while inhibition of endogenous hsa-miR-296-5p facilitated, EV71 infection. Additionally, two potential hsa-miR-296-5p targets (nt 2115 to 2135 and nt 2896 to 2920) located in the EV71 genome (strain BrCr) were bioinformatically predicted and validated by luciferase reporter assays and Western blotting. Genomic alignment of various EV71 strains revealed synonymous mutations in hsa-miR-296-5p target sequences. Furthermore, the introduction of synonymous mutations into the EV71 BrCr genome by site-directed mutagenesis impaired the viral inhibitory effects of hsa-miR-296-5p and facilitated mutant virus infection. Meanwhile, compensatory mutations in corresponding hsa-miR-296-5p target sequences of the EV71 HeN strain (GenBank accession number JN256064) restored the inhibitory effects of the miRNA. These results indicate that hsa-miR-296-5p inhibits EV71 replication by targeting the viral genome. Our findings support the notion that cellular miRNAs can inhibit virus infection and that the virus mutates to escape suppression by cellular miRNAs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Zhenhua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Xianliang</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meng</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Siyi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Caishang</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhenfeng</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hanzhong</ForeName><Initials>H</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>GENBANK</DataBankName><AccessionNumberList><AccessionNumber>JN256064</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C549871">MIRN296 microRNA, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035683">MicroRNAs</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="Y">Host-Pathogen Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035683" MajorTopicYN="N">MicroRNAs</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060888" MajorTopicYN="N">Real-Time Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017422" MajorTopicYN="N">Sequence Analysis, DNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="Y">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23468506</ArticleId><ArticleId IdType="pmc">PMC3648165</ArticleId><ArticleId IdType="doi">10.1128/JVI.02655-12</ArticleId><ArticleId IdType="pii">JVI.02655-12</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ghildiyal M, Zamore PD. 2009. Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 10:94&#x2013;108</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2724769</ArticleId><ArticleId IdType="pubmed">19148191</ArticleId></ArticleIdList></Reference><Reference><Citation>Moazed D. 2009. Small RNAs in transcriptional gene silencing and genome defence. Nature 457:413&#x2013;420</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3246369</ArticleId><ArticleId IdType="pubmed">19158787</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalsky RL, Cullen BR. 2010. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol. 64:123&#x2013;141</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3621958</ArticleId><ArticleId IdType="pubmed">20477536</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartel DP. 2009. MicroRNAs: target recognition and regulatory functions. Cell 136:215&#x2013;233</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3794896</ArticleId><ArticleId IdType="pubmed">19167326</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen BR. 2009. Viral and cellular messenger RNA targets of viral microRNAs. Nature 457:421&#x2013;425</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3074184</ArticleId><ArticleId IdType="pubmed">19158788</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla GC, Singh J, Barik S. 2011. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol. 3:83&#x2013;92</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3315687</ArticleId><ArticleId IdType="pubmed">22468167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Kolb FA, Jaskiewicz L, Westhof E, Filipowicz W. 2004. Single processing center models for human Dicer and bacterial RNase III. Cell 118:57&#x2013;68</Citation><ArticleIdList><ArticleId IdType="pubmed">15242644</ArticleId></ArticleIdList></Reference><Reference><Citation>Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L, Rappsilber J, Mann M, Dreyfuss G. 2002. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16:720&#x2013;728</Citation><ArticleIdList><ArticleId IdType="pmc">PMC155365</ArticleId><ArticleId IdType="pubmed">11914277</ArticleId></ArticleIdList></Reference><Reference><Citation>Meister G, Tuschl T. 2004. Mechanisms of gene silencing by double-stranded RNA. Nature 431:343&#x2013;349</Citation><ArticleIdList><ArticleId IdType="pubmed">15372041</ArticleId></ArticleIdList></Reference><Reference><Citation>
Brennecke J, Stark A, Russell RB, Cohen SM.
2005. 
Principles of microRNA-target recognition. PLoS Biol. 3:e85
doi:10.1371/journal.pbio.0030085</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0030085</ArticleId><ArticleId IdType="pmc">PMC1043860</ArticleId><ArticleId IdType="pubmed">15723116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuersten S, Goodwin EB. 2003. The power of the 3&#x2032; UTR: translational control and development. Nat. Rev. Genet. 4:626&#x2013;637</Citation><ArticleIdList><ArticleId IdType="pubmed">12897774</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai EC. 2002. Micro RNAs are complementary to 3&#x2032; UTR sequence motifs that mediate negative post-transcriptional regulation. Nat. Genet. 30:363&#x2013;364</Citation><ArticleIdList><ArticleId IdType="pubmed">11896390</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkhout B, Jeang KT. 2007. RISCy business: microRNAs, pathogenesis, and viruses. J. Biol. Chem. 282:26641&#x2013;26645</Citation><ArticleIdList><ArticleId IdType="pubmed">17627941</ArticleId></ArticleIdList></Reference><Reference><Citation>Voinnet O. 2005. Induction and suppression of RNA silencing: insights from viral infections. Nat. Rev. Genet. 6:206&#x2013;220</Citation><ArticleIdList><ArticleId IdType="pubmed">15703763</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T. 2004. Identification of virus-encoded microRNAs. Science 304:734&#x2013;736</Citation><ArticleIdList><ArticleId IdType="pubmed">15118162</ArticleId></ArticleIdList></Reference><Reference><Citation>Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, Cullen BR. 2008. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454:780&#x2013;783</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2666538</ArticleId><ArticleId IdType="pubmed">18596690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain M, Torres S, Schnettler E, Funk A, Grundhoff A, Pijlman GP, Khromykh AA, Asgari S. 2012. West Nile virus encodes a microRNA-like small RNA in the 3&#x2032; untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells. Nucleic Acids Res. 40:2210&#x2013;2223</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3300009</ArticleId><ArticleId IdType="pubmed">22080551</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller S. 2007. Dicing with viruses: microRNAs as antiviral factors. Immunity 27:1&#x2013;3</Citation><ArticleIdList><ArticleId IdType="pubmed">17663977</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O. 2005. A cellular microRNA mediates antiviral defense in human cells. Science 308:557&#x2013;560</Citation><ArticleIdList><ArticleId IdType="pubmed">15845854</ArticleId></ArticleIdList></Reference><Reference><Citation>Otsuka M, Jing Q, Georgel P, New L, Chen JM, Mols J, Kang YJ, Jiang ZF, Du X, Cook R, Das SC, Pattnaik AK, Beutler B, Han JH. 2007. Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. Immunity 27:123&#x2013;134</Citation><ArticleIdList><ArticleId IdType="pubmed">17613256</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. 2007. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449:919&#x2013;922</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2748825</ArticleId><ArticleId IdType="pubmed">17943132</ArticleId></ArticleIdList></Reference><Reference><Citation>Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A. 2011. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res. 39:5157&#x2013;5163</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3130258</ArticleId><ArticleId IdType="pubmed">21317190</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YN, Shen A, Rider PJ, Yu Y, Wu KL, Mu YX, Hao Q, Liu YL, Gong H, Zhu Y, Liu FY, Wu JG. 2011. A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication. FASEB J. 25:4511&#x2013;4521</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3236624</ArticleId><ArticleId IdType="pubmed">21903935</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM. 2009. Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 34:696&#x2013;709</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763548</ArticleId><ArticleId IdType="pubmed">19560422</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennasser Y, Le SY, Benkirane M, Jeang KT. 2005. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22:607&#x2013;619</Citation><ArticleIdList><ArticleId IdType="pubmed">15894278</ArticleId></ArticleIdList></Reference><Reference><Citation>Haasnoot J, de Vries W, Geutjes EJ, Prins M, de Haan P, Berkhout B. 2007. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 3:794&#x2013;803</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1894824</ArticleId><ArticleId IdType="pubmed">17590081</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, Shih SR, Ning HC, Hwang MS, Wang HS, Lee CY. 1999. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 354:1682&#x2013;1686</Citation><ArticleIdList><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>
Cui L, Guo X, Qi Y, Qi X, Ge Y, Shi Z, Wu T, Shan J, Shan Y, Zhu Z, Wang H.
2010. 
Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J. Biomed. Biotechnol. 2010:425939
doi:10.1155/2010/425939</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/425939</ArticleId><ArticleId IdType="pmc">PMC2896697</ArticleId><ArticleId IdType="pubmed">20625495</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho BC, Yu SL, Chen JJ, Chang SY, Yan BS, Hong QS, Singh S, Kao CL, Chen HY, Su KY, Li KC, Cheng CL, Cheng HW, Lee JY, Lee CN, Yang PC. 2011. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 9:58&#x2013;69</Citation><ArticleIdList><ArticleId IdType="pubmed">21238947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Qin Y, Tong L, Wu S, Wang Q, Jiao Q, Guo Z, Lin L, Wang R, Zhao W, Zhong Z. 2012. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Antiviral Res. 93:270&#x2013;279</Citation><ArticleIdList><ArticleId IdType="pubmed">22197249</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T. 2005. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J. Gen. Virol. 86:1391&#x2013;1401</Citation><ArticleIdList><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W. 2009. Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat. Med. 15:31&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">19122656</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson L, Hjalmarsson A, Everitt E. 1999. TCID50 determination by an immuno dot blot assay as exemplified in a study of storage conditions of infectious pancreatic necrosis virus. J. Virol. Methods 80:17&#x2013;24</Citation><ArticleIdList><ArticleId IdType="pubmed">10403672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei JJ, Wu X, Peng Y, Shi G, Basturk O, Yang X, Daniels G, Osman I, Ouyang J, Hernando E, Pellicer A, Rhim JS, Melamed J, Lee P. 2011. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion. Clin. Cancer Res. 17:1297&#x2013;1305</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196617</ArticleId><ArticleId IdType="pubmed">21138859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu PW, Lin LZ, Hsu SD, Hsu JB, Huang HD. 2007. ViTa: prediction of host microRNAs targets on viruses. Nucleic Acids Res. 35:D381&#x2013;D385</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1761424</ArticleId><ArticleId IdType="pubmed">17148483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh Z, Mallick B, Chakrabarti J. 2009. Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res. 37:1035&#x2013;1048</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2651794</ArticleId><ArticleId IdType="pubmed">19095692</ArticleId></ArticleIdList></Reference><Reference><Citation>
Tsunetsugu-Yokota Y, Yamamoto T.
2010. 
Mammalian microRNAs: post-transcriptional gene regulation in RNA virus infection and therapeutic applications. Front. Microbiol. 1:108
doi:10.3389/fmicb.2010.00108</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2010.00108</ArticleId><ArticleId IdType="pmc">PMC3095394</ArticleId><ArticleId IdType="pubmed">21607080</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini I, Bisceglia M, Beck-Peccoz P, Bosari S, Spada A. 2010. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr. Relat. Cancer 17:135&#x2013;146</Citation><ArticleIdList><ArticleId IdType="pubmed">19926710</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong L, Han Y, Zhang HW, Li MB, Gong TQ, Sun L, Wu KC, Zhao QC, Fan DM. 2010. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann. Surg. 251:1056&#x2013;1063</Citation><ArticleIdList><ArticleId IdType="pubmed">20485139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wurdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO, Krichevsky AM. 2008. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 14:382&#x2013;393</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2597164</ArticleId><ArticleId IdType="pubmed">18977327</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, Zingale A, Baccarini A, Lazzari G, Galli C, Naldini L. 2007. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 25:1457&#x2013;1467</Citation><ArticleIdList><ArticleId IdType="pubmed">18026085</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. 2012. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J. Virol. 86:3767&#x2013;3776</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3302529</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId></ArticleIdList></Reference><Reference><Citation>Gottwein E, Cullen BR. 2008. Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3:375&#x2013;387</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3079432</ArticleId><ArticleId IdType="pubmed">18541214</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng AM, Byrom MW, Shelton J, Ford LP. 2005. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res. 33:1290&#x2013;1297</Citation><ArticleIdList><ArticleId IdType="pmc">PMC552951</ArticleId><ArticleId IdType="pubmed">15741182</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H. 2010. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210. Antiviral Res. 88:169&#x2013;175</Citation><ArticleIdList><ArticleId IdType="pubmed">20728471</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H. 2007. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13:1241&#x2013;1247</Citation><ArticleIdList><ArticleId IdType="pubmed">17906637</ArticleId></ArticleIdList></Reference><Reference><Citation>Jopling CL, Yi MK, Lancaster AM, Lemon SM, Sarnow P. 2005. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 309:1577&#x2013;1581</Citation><ArticleIdList><ArticleId IdType="pubmed">16141076</ArticleId></ArticleIdList></Reference><Reference><Citation>Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M. 2007. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315:1579&#x2013;1582</Citation><ArticleIdList><ArticleId IdType="pubmed">17322031</ArticleId></ArticleIdList></Reference><Reference><Citation>Robson JE, Eaton SA, Underhill P, Williams D, Peters J. 2012. MicroRNAs 296 and 298 are imprinted and part of the GNAS/Gnas cluster and miR-296 targets IKBKE and Tmed9. RNA 18:135&#x2013;144</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3261735</ArticleId><ArticleId IdType="pubmed">22114321</ArticleId></ArticleIdList></Reference><Reference><Citation>Novella IS, Zarate S, Metzgar D, Ebendick-Corpus BE. 2004. Positive selection of synonymous mutations in vesicular stomatitis virus. J. Mol. Biol. 342:1415&#x2013;1421</Citation><ArticleIdList><ArticleId IdType="pubmed">15364570</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamano T, Matsuo K, Hibi Y, Victoriano AF, Takahashi N, Mabuchi Y, Soji T, Irie S, Sawanpanyalert P, Yanai H, Hara T, Yamazaki S, Yamamoto N, Okamoto T. 2007. A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production. J. Virol. 81:1528&#x2013;1533</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1797536</ArticleId><ArticleId IdType="pubmed">17121798</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman JR, Papamichail D, Skiena S, Futcher B, Wimmer E, Mueller S. 2008. Virus attenuation by genome-scale changes in codon pair bias. Science 320:1784&#x2013;1787</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2754401</ArticleId><ArticleId IdType="pubmed">18583614</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R. 2008. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4:239&#x2013;248</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605097</ArticleId><ArticleId IdType="pubmed">18779050</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin L, Stone JK, Andino R. 2005. Poliovirus escape from RNA interference: short interfering RNA-target recognition and implications for therapeutic approaches. J. Virol. 79:1027&#x2013;1035</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538575</ArticleId><ArticleId IdType="pubmed">15613331</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss BL, Maximova OA, Thach DC, Speicher JM, Pletnev AG. 2012. MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype. J. Virol. 86:5647&#x2013;5659</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3347253</ArticleId><ArticleId IdType="pubmed">22419812</ArticleId></ArticleIdList></Reference><Reference><Citation>
Lin SS, Wu HW, Elena SF, Chen KC, Niu QW, Yeh SD, Chen CC, Chua NH.
2009. 
Molecular evolution of a viral non-coding sequence under the selective pressure of amiRNA-mediated silencing. PLoS Pathog. 5:e1000312
doi:10.1371/journal.ppat.1000312</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000312</ArticleId><ArticleId IdType="pmc">PMC2642722</ArticleId><ArticleId IdType="pubmed">19247440</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss BL, Maximova OA, Pletnev AG. 2011. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J. Virol. 85:1464&#x2013;1472</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3028900</ArticleId><ArticleId IdType="pubmed">21123372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinnunen L, Huovilainen A, Poyry T, Hovi T. 1990. Rapid molecular evolution of wild type 3 poliovirus during infection in individual hosts. J. Gen. Virol. 71(Part 2):317&#x2013;324</Citation><ArticleIdList><ArticleId IdType="pubmed">2155286</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>